(Q39871995)

15 September 2017

Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo (English)

1 reference

15 September 2017

Qiong Zhong

1

1 reference

15 September 2017

Zhanqiu Yang

2

1 reference

15 September 2017

Yuanyuan Liu

3

1 reference

15 September 2017

Haiying Deng

4

1 reference

15 September 2017

Hong Xiao

5

1 reference

15 September 2017

Liqiao Shi

6

1 reference

15 September 2017

Jing He

7

1 reference

15 September 2017

language of work or name

1 reference

17 March 2009

1 reference

15 September 2017

1 reference

15 September 2017

154

1 reference

15 September 2017

4

1 reference

15 September 2017

601-607

1 reference

https://scigraph.springernature.com/pub.10.1007/s00705-009-0346-4

15 September 2017

0 references

cites work

Evidence for enteroviral persistence in humans

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00705-009-0346-4

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection

21 January 2018

1 reference

12 December 2020

Treatment of picornavirus infections

1 reference

12 December 2020

Coxsackieviruses and diabetes

1 reference

12 December 2020

High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis

1 reference

12 December 2020

Reemergence of an epidemic coxsackievirus B5 genotype

1 reference

12 December 2020

Picornavirus inhibitors

1 reference

12 December 2020

Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice

1 reference

12 December 2020

Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo

1 reference

12 December 2020

Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin

1 reference

12 December 2020

Membrane fusion activity of influenza virus.

1 reference

12 December 2020

1 reference

12 December 2020

Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives

1 reference

12 December 2020

Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A

1 reference

12 December 2020

DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice

1 reference

12 December 2020

Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy

1 reference

12 December 2020

Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization.

1 reference

12 December 2020

Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3-carboxylates

1 reference

12 December 2020

Successful treatment of Epstein-Barr virus infection associated with myocarditis

1 reference

12 December 2020

Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?

1 reference

12 December 2020

Study of the effect of antiviral drugs on the reproduction of the respiratory syncytial virus by enzyme immunoassay

1 reference

12 December 2020

Complete heart block in a child with varicella

1 reference

12 December 2020

A left superior vena cava draining the blood from a closed coronary sinus.

1 reference

12 December 2020

Arbidol: a broad-spectrum antiviral compound that blocks viral fusion

1 reference

12 December 2020

10.1007/S00705-009-0346-4

Identifiers

DOI

1 reference

15 September 2017

0 references

1 reference